Better drug delivery in cancer
EPFL and Novochizol SA to collaborate on designing more efficient immunotherapies,
with the support of Innosuisse, the Swiss Innovation Agency.
What is NovochizolTM?
Novochizol™ technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres. They can be used alone for their anti-inflammatory and immune-stimulating properties or as bioadherent carriers. Any type of biologically active substance can be formulated: small molecules, peptides, nucleic acids, and proteins. Novochizol™ retains all the benefits of chitosan and overcomes all of its limitations, offering first-in-class solutions in therapeutics, diagnostics, tissue engineering, and material sciences.
Why use NovochizolTM?
- Strong adherence to tissues or materials at site of application.
- Injectable, oral, or topical formulations, aerosols, solid matrices.
- Sustained local release of any API, without systemic distribution.
- Intracellular delivery of even large proteins targeting a variety of
cell types. - Formulation of even the most recalcitrant active ingredients.
- Safety profile inherited from chitosan (GRAS).
- Numerous applications in pharma, medical devices, agriculture
and cosmetics.
For more Information
Benefits of Novochizol™
News
A revolution in the global chitosan industry
Alpha Chitin and Novochizol SA join efforts to produce a chitosan-based polysaccharide with unique properties... Read more
The current Covid-19 vaccines aim at preventing illness and death. This is wonderful. But they are not designed to eliminate the virus itself, nor prevent its transmission.... Read more
"Impossible n'est pas français" (Napoléon)
History proved Napoleon not exactly right... But what if "Formulation impossible n'est pas Novochizol" were true?
Challenge us !
(you may even win a box of Swiss chocolates...) Read more
